Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.71 USD | -1.20% | +19.60% | +18.29% |
May. 03 | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
Mar. 07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.29% | 634M | |
+21.06% | 46.81B | |
-0.76% | 41.37B | |
+47.19% | 41.29B | |
-6.20% | 28.87B | |
+10.75% | 26.06B | |
-20.70% | 19.13B | |
+31.14% | 12.39B | |
+0.23% | 12.08B | |
-0.61% | 11.96B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Earnings Flash (PHAT) PHATHOM PHARMACEUTICALS Posts Q3 Loss $-0.98